FORNIX BIOSCIENCES N V has a total of 28 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), Canada and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MEDIGENE IMMUNOTHERAPIES GMBH, MOGAM INST BIOMEDICAL RES and INST BIOTECHNOLOGII I ANTYBIOTYKOW.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | Canada | 6 | |
#3 | United States | 6 | |
#4 | Australia | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 4 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Nijkamp Franciscus Petrus | 11 |
#2 | Blalock James Edwin | 9 |
#3 | Haddox Jeffrey Lynn | 9 |
#4 | Villain Matteo | 9 |
#5 | Redegeld Franciscus Antonius M | 7 |
#6 | Kraneveld Aletta Desiree | 7 |
#7 | Roossien Folkert Feiko | 6 |
#8 | Ubink-Bontekoe Carola Jacoba M | 6 |
#9 | Visser Tjerk Johannes Anske | 5 |
#10 | Pfister Rosswell Robert | 5 |
Publication | Filing date | Title |
---|---|---|
WO2005103717A1 | Measuring free light chains of immunoglobulin | |
EP1487971A2 | MEANS AND METHODS FOR MANIPULATING HYPERSENSITIVITY−LIKE RESPONSES | |
US7223740B2 | Vectors for enhanced expression of VEGF for atrial disease treatment | |
EP1395292A2 | Vectors for enhanced expression of vegf for disease treatment | |
EP1342779A1 | Means and methods for manipulating hypersensitivity-like responses | |
EP1262199A1 | Vectors for enhanced expression of VEGF for disease treatment | |
EP1176189A1 | Stem cell-like cells | |
EP1131341A1 | Compound for inhibiting the influx of polymorphonuclear leukocytes (pmns) in a tissue, it's selection, pharmaceuticial compositions and use | |
CA2366678A1 | Synthetic complementary peptides and ophthalmologic uses thereof |